Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm Trial

BACKGROUND: Gastric cancer occupies the fourth highest morbidity rate of cancers worldwide. A higher incidence of gastric cancer had been found in East Asia compared to the other regions. Gastrectomy with radical lymph node dissection is the cornerstone of curative treatment for Stage III gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zhongyi, Ni, Bo, Yang, Linxi, Guan, Yujing, Zhu, Chunchao, Zhao, Enhao, Zhao, Gang, Xia, Xiang, Zhang, Zizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274117/
https://www.ncbi.nlm.nih.gov/pubmed/35836597
http://dx.doi.org/10.3389/fsurg.2022.917352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274117/
https://www.ncbi.nlm.nih.gov/pubmed/35836597
http://dx.doi.org/10.3389/fsurg.2022.917352

Ejemplares similares